表紙
市場調查報告書

全球表觀遺傳學藥物及診斷技術市場:產業分析,規模,佔有率,成長,趨勢,預測

Global Epigenetics Drugs And Diagnostic Technologies Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

出版商 Value Market Research 商品編碼 838386
出版日期 內容資訊 英文 125 Pages
商品交期: 最快1-2個工作天內
價格
全球表觀遺傳學藥物及診斷技術市場:產業分析,規模,佔有率,成長,趨勢,預測 Global Epigenetics Drugs And Diagnostic Technologies Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026
出版日期: 2020年05月01日內容資訊: 英文 125 Pages
簡介

本報告提供全球表觀遺傳學藥物及診斷技術市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介相關資訊。

第1章 簡介

第2章 摘要整理

第3章 市場分析

  • 簡介
  • 價值鏈分析
  • 促進要素
  • 阻礙要素
  • 機會
  • 波特五力分析

第4章 各藥物作用機制市場分析

  • DNMT抑制劑
  • Azacitidine
  • Decitabine
  • HDAC抑制劑
  • Vorinostat
  • Romidepsin

第5章 各技術類型市場分析

  • DNA甲基化
  • 染色質免疫沉澱(ChIP)技術

第6章 各地區市場分析

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 競爭環境

  • 市場上競爭
  • 聯盟/聯合/協定
  • 合併·收購
  • 新產品上市
  • 其他開發

第8章 企業簡介

  • 4SC AG
  • Acetylon Pharmaceuticals, Inc.
  • Astex Pharmaceuticals Inc.
  • Celenge
  • CellCentric Ltd.
  • Celleron Therapeutics Ltd.
  • Chroma Therapeutics Ltd.
  • Eisai
  • EnVivo Pharmaceuticals Inc.
  • Epigentek Group Inc.
  • Epizyme, Inc. Illumina Inc.
  • MDxHealth
  • Merck
  • Merck & Company Inc.
  • Novartis International AG
  • Oncolys BioPharma Inc.
  • Pharmacyclics
  • Promega Corporation
  • Spectrum Pharmaceuticals
  • Syndax Pharmaceuticals, Inc.
  • Topotarget A/S
  • Valirx Plc

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Value Market Research's latest report on the Global Epigenetics Drugs And Diagnostic Technologies Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2020-2026.

The global epigenetics drugs and diagnostic technologies market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global epigenetics drugs and diagnostic technologies market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global epigenetics drugs and diagnostic technologies market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global epigenetics drugs and diagnostic technologies market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global epigenetics drugs and diagnostic technologies market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global epigenetics drugs and diagnostic technologies market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global epigenetics drugs and diagnostic technologies market.

The market analysis involves a section exclusively to list the major players of the global epigenetics drugs and diagnostic technologies market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Epigenetics Drugs And Diagnostic Technologies Market Report Segments the market as below -

By Drugs Mechanism Of Action

DNMT Inhibitors

Azacitidine (Vidaza)

Decitabine (Dacogen)

HDAC Inhibitors

Vorinostat (Zolinza)

Romidepsin (Istodax)

By Technology Types

DNA Methylation

Chromatin Immunoprecipitation (ChIP) Technology

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Epigenetics Drugs And Diagnostic Technologies Market
  • 2.2. Global Epigenetics Drugs And Diagnostic Technologies Market Snapshot

3 . EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Epigenetics Drugs And Diagnostic Technologies Market
  • 3.3. Market Restraints of Epigenetics Drugs And Diagnostic Technologies Market
  • 3.4. Opportunities of Epigenetics Drugs And Diagnostic Technologies Market
  • 3.5. Trends of Epigenetics Drugs And Diagnostic Technologies Market
  • 3.6. Porter's Five Force Analysis of Epigenetics Drugs And Diagnostic Technologies Market
  • 3.7. Epigenetics Drugs And Diagnostic Technologies Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Drugs Mechanism Of Action
    • 3.7.2 Market Attractive Analysis by Technology Types
    • 3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Epigenetics Drugs And Diagnostic Technologies Value Chain Analysis
  • 4.2. Epigenetics Drugs And Diagnostic Technologies Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Epigenetics Drugs And Diagnostic Technologies Raw Material Manufactures List
    • 4.2.3. Price Trend of Epigenetics Drugs And Diagnostic Technologies Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES MARKET ANALYSIS BY DRUGS MECHANISM OF ACTION

  • 5.1 Overview by Drugs Mechanism Of Action
  • 5.2 Global Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action
  • 5.3 Market Analysis of DNMT Inhibitors by Regions
  • 5.4 Market Analysis of HDAC Inhibitors by Regions

6 . GLOBAL EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES MARKET ANALYSIS BY TECHNOLOGY TYPES

  • 6.1 Overview by Technology Types
  • 6.2 Global Epigenetics Drugs And Diagnostic Technologies Market Analysis by Technology Types
  • 6.3 Market Analysis of DNA Methylation by Regions
  • 6.4 Market Analysis of Chromatin Immunoprecipitation (ChIP) Technology by Regions

7 . GLOBAL EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America
    • 7.3.1. Overview
    • 7.3.2. North America Epigenetics Drugs And Diagnostic Technologies Market Estimate by Market Segment
    • 7.3.3. North America Epigenetics Drugs And Diagnostic Technologies Market Estimate by Country
    • 7.3.4. United State
    • 7.3.5. Rest of North America
  • 7.4. Europe
    • 7.4.1. Overview
    • 7.4.2. Europe Epigenetics Drugs And Diagnostic Technologies Market Estimate by Market Segment
    • 7.4.3. Europe Epigenetics Drugs And Diagnostic Technologies Market Estimate by Country
    • 7.4.4. United Kingdom
    • 7.4.5. France
    • 7.4.6. Germany
    • 7.4.7 Rest of Europe
  • 7.5. Asia Pacific
    • 7.5.1. Overview
    • 7.5.2. Asia Pacific Epigenetics Drugs And Diagnostic Technologies Market Estimate by Market Segment
    • 7.5.3. Asia Pacific Epigenetics Drugs And Diagnostic Technologies Market Estimate by Country
    • 7.5.4. China
    • 7.5.5. Japan
    • 7.5.6. India
    • 7.5.7. Rest of Asia Pacific
  • 7.6. Latin America
    • 7.6.1. Overview
    • 7.6.2. Latin America Epigenetics Drugs And Diagnostic Technologies Market Estimate by Market Segment
    • 7.6.3. Latin America Epigenetics Drugs And Diagnostic Technologies Market Estimate by Country
    • 7.6.4. Brazil
    • 7.6.5. Rest of Latin America
  • 7.7. Middle East & Africa
    • 7.7.1. Overview
    • 7.7.2. Middle East & Africa Epigenetics Drugs And Diagnostic Technologies Market Estimate by Market Segment
    • 7.7.3. Middle East & Africa Epigenetics Drugs And Diagnostic Technologies Market Estimate by Country
    • 7.7.4. Middle East
    • 7.7.5. Africa

8 . COMPETITIVE LANDSCAPE OF THE EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES COMPANIES

  • 8.1. Epigenetics Drugs And Diagnostic Technologies Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES INDUSTRY

  • 9.1. Company Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. 4SC AG
    • 9.3.1. Company Overview
    • 9.3.2. Financials
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Acetylon Pharmaceuticals, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financials
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Astex Pharmaceuticals Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financials
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Celenge
    • 9.6.1. Company Overview
    • 9.6.2. Financials
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. CellCentric Ltd.
    • 9.7.1. Company Overview
    • 9.7.2. Financials
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Celleron Therapeutics Ltd.
    • 9.8.1. Company Overview
    • 9.8.2. Financials
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Chroma Therapeutics Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Financials
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Eisai Pharmaceuticals
    • 9.10.1. Company Overview
    • 9.10.2. Financials
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. EnVivo Pharmaceuticals Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Financials
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Epigentek Group Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Financials
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Epizyme, Inc. Illumina Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Financials
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. MDxHealth
    • 9.14.1. Company Overview
    • 9.14.2. Financials
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. Merck
    • 9.15.1. Company Overview
    • 9.15.2. Financials
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. Merck & Company Inc.
    • 9.16.1. Company Overview
    • 9.16.2. Financials
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. Novartis International AG
    • 9.17.1. Company Overview
    • 9.17.2. Financials
    • 9.17.3. Products
    • 9.17.4. Recent Developments
  • 9.18. Oncolys BioPharma Inc.
    • 9.18.1. Company Overview
    • 9.18.2. Financials
    • 9.18.3. Products
    • 9.18.4. Recent Developments

10. IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 10.1. Impact Analysis of Covid-19 Outbreak on the Market
    • 10.1.1. Direct Impact on Production
    • 10.1.2. Supply Chain and Market Disruption
    • 10.1.3. Financial Impact on Firms and Financial Markets
  • 10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 10.3. Pre V/S Post COVID-19 Market
  • 10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
  • 10.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Global Epigenetics Drugs And Diagnostic Technologies Market Analysis in DNMT Inhibitors by Geography (USD MN)
  • Global Epigenetics Drugs And Diagnostic Technologies Market Analysis in HDAC Inhibitors by Geography (USD MN)
  • Global Epigenetics Drugs And Diagnostic Technologies Market Analysis by Technology Types (USD MN)
  • Global Epigenetics Drugs And Diagnostic Technologies Market Analysis in DNA Methylation by Geography (USD MN)
  • Global Epigenetics Drugs And Diagnostic Technologies Market Analysis in Chromatin Immunoprecipitation (ChIP) Technology by Geography (USD MN)
  • Global Epigenetics Drugs And Diagnostic Technologies Market by Geography (USD MN)
  • North America Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • North America Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • North America Epigenetics Drugs And Diagnostic Technologies Market Estimate by Country (USD MN)
  • United State Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • United State Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Rest of North America Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Rest of North America Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Europe Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Europe Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • United Kingdom Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • United Kingdom Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • France Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • France Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Germany Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Germany Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Rest of Europe Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Rest of Europe Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Asia Pacific Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Asia Pacific Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Asia Pacific Epigenetics Drugs And Diagnostic Technologies Market Estimate by Country (USD MN)
  • China Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • China Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Japan Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Japan Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • India Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • India Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Rest of Asia Pacific Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Rest of Asia Pacific Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Latin America Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Latin America Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Latin America Epigenetics Drugs And Diagnostic Technologies Market Estimate by Country (USD MN)
  • Brazil Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Brazil Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Rest of Latin America Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Rest of Latin America Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Middle East & Africa Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Middle East & Africa Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Middle East & Africa Epigenetics Drugs And Diagnostic Technologies Market Estimate by Country (USD MN)
  • Middle East Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Middle East Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Africa Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Africa Epigenetics Drugs And Diagnostic Technologies Market Estimate by Technology Types (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019

LIST OF FIGURES

  • Research Scope of Epigenetics Drugs And Diagnostic Technologies Report
  • Market Research Process
  • Market Research Methodology
  • Global Epigenetics Drugs And Diagnostic Technologies Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drugs Mechanism Of Action
  • Market Attractiveness Analysis by Technology Types
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Epigenetics Drugs And Diagnostic Technologies Market Analysis by Drugs Mechanism Of Action (USD MN)
  • Global Epigenetics Drugs And Diagnostic Technologies Market Analysis in DNMT Inhibitors by Geography (USD MN)
  • Global Epigenetics Drugs And Diagnostic Technologies Market Analysis in HDAC Inhibitors by Geography (USD MN)
  • Global Epigenetics Drugs And Diagnostic Technologies Market Analysis by Technology Types (USD MN)
  • Global Epigenetics Drugs And Diagnostic Technologies Market Analysis in DNA Methylation by Geography (USD MN)
  • Global Epigenetics Drugs And Diagnostic Technologies Market Analysis in Chromatin Immunoprecipitation (ChIP) Technology by Geography (USD MN)
  • Latin America Epigenetics Drugs And Diagnostic Technologies Market by Revenue
  • Middle East & Africa Epigenetics Drugs And Diagnostic Technologies Market by Revenue
  • Recent Development in Epigenetics Drugs And Diagnostic Technologies Industry
  • Company Market Share Analysis, 2019
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.